Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
2.
Journal of Gynecologic Oncology ; : 105-110, 2014.
Artigo em Inglês | WPRIM | ID: wpr-16242

RESUMO

OBJECTIVE: Stage II endometrial cancer is relatively uncommon. There is no consensus for appropriate adjuvant therapy in endometrial cancer patients with cervical stromal involvement (International Federation of Gynecology and Obstetrics [FIGO] stage II). This study investigates how adjuvant treatments and tumor characteristics influence overall survival (OS) and disease-free survival (DFS) in stage II patients in order to establish better treatment guidelines. METHODS: This multi-institution, Institutional Review Board approved, study is a retrospective review of 40 endometrial cancer patients with cervical stromal involvement treated from 1993 to 2009. Kaplan-Meier estimates were used to evaluate OS and DFS. RESULTS: OS was 85% at three years and 67% at five years. There were no significant differences in age, histology, depth of invasion, comorbid conditions, surgical staging or recurrence between patients who received radiation therapy (RT) and those who did not. However, patients with FIGO grade 1 cancers were less likely to receive RT (p=0.007). Patients treated with RT had a similar 5 year OS (n=33, 69%) to those treated with surgery only (n=7, 60%, p=0.746). There were no OS differences when evaluating by grade, histology, or depth of invasion between patients who did and did not receive RT. Four patients recurred: three were locoregional failures only, and one failed locally and distant. CONCLUSION: Patients receiving RT had higher grade tumors. Despite this, OS was comparable between the RT and the no RT cohorts. Local failure was the predominant pattern of failure. Endometrial cancer patients with cervical stromal involvement likely receive better locoregional control with the addition of adjuvant RT and we continue to advocate for RT in most cases.


Assuntos
Feminino , Humanos , Estudos de Coortes , Consenso , Intervalo Livre de Doença , Neoplasias do Endométrio , Comitês de Ética em Pesquisa , Ginecologia , Obstetrícia , Recidiva , Estudos Retrospectivos , Análise de Sobrevida
3.
Journal of Gynecologic Oncology ; : 207-209, 2012.
Artigo em Inglês | WPRIM | ID: wpr-131074

RESUMO

No abstract available.

4.
Journal of Gynecologic Oncology ; : 207-209, 2012.
Artigo em Inglês | WPRIM | ID: wpr-131071

RESUMO

No abstract available.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA